Thermo Fisher price target raised to $580 from $545 at Leerink

Leerink raised the firm’s price target on Thermo Fisher (TMO) to $580 from $545 and keeps an Outperform rating on the shares following an “in-line” Q3 earnings report with a “minimal” FY25 guidance raise and “no real surprises.” The firm remains Outperform-rated on Thermo Fisher given its view that the company is a leader in Life Science Tools, with “unmatched scale and reach in the research labs market combined with a number of growth products serving key end-markets.” Leerink believes the company should continue to hold its position as “the leading lab tools and supplies provider and post strong growth.”